跳至主要内容
临床试验/NCT05538728
NCT05538728已完成不适用

A Prospective Open-label Study to Evaluate Safety and Effectiveness of Two Different Reconstitution Volumes of Poly-l-lactic Acid (PLLA) for Correction of Wrinkles in the décolletage Area

Galderma R&D3 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Galderma R&D
入组人数
30
试验地点
3
主要终点
Percentage of Responders on the Galderma Décolletage Scale (GDS), as Assessed Live by the Treating Investigator, at Month 9

研究概览

简要总结

This is a prospective open-label study to evaluate safety and effectiveness of two different reconstitution volumes of poly-l-lactic acid (PLLA) for correction of wrinkles in the décolletage area.

详细描述

A challenge for wrinkle correction of the decolletage/chest and other non-facial areas is that larger surface areas typically need to be treated than for facial indications, for which reason the Sponsor is investigating a larger reconstitution volume compared to the approved label. In this study, the total volume of 18mL, including 1mL of 2% lidocaine, is being explored and compared with results from the current labeled volume of 9mL, including lidocaine, to assess if the larger volume is well-tolerated for treatment for wrinkles in the decolletage area.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Non-pregnant, non-breastfeeding females over the age of 22
  • subjects seeking treatment for the décolletage
  • subjects with moderate (Grade 2) or severe (Grade 3) on the Galderma Décolletage Scale
  • subjects willing to abstain from any other surgical or cosmetic procedures in the décolletage area for the duration of the study.

排除标准

  • Known/previous allergy or hypersensitivity to Sculptra
  • Previous tissue augmenting therapy, contouring or revitalization treatment in the décolletage prior to baseline
  • Any plastic surgery or permanent surgical implant in the treatment area
  • Previous treatment/procedure in the treatment area in the previous 6 months that would interfere with study injections or study assessments

结局指标

主要结局

Percentage of Responders on the Galderma Décolletage Scale (GDS), as Assessed Live by the Treating Investigator, at Month 9

时间窗: At Month 9

Responder was defined as participants having at least one grade improvement from baseline. GDS was a validated 5-point scale used to assess the severity of lines and wrinkles in the décolletage area: Grade 0 (none to minimal), Grade 1 (mild), Grade 2 (moderate), Grade 3 (severe), Grade 4 (very severe). Higher score meant very severe lines and wrinkles in the décolletage area.

次要结局

  • Percentage of Responders on the Galderma Décolletage Scale, as Assessed Live by the Treating Investigator, at Month 6(At Month 6)
  • Percentage of Responders Who Achieved At Least "Improved" on the Global Aesthetic Improvement Scale (GAIS) as Assessed by Participant at Months 6 and 9(At Month 6 and 9)
  • Percentage of Responders With At Least "Improved" on the Global Aesthetic Improvement Scale (GAIS) as Assessed by Treating Investigator at Months 6 and 9(At Months 6 and 9)

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验